CN100394925C - Chinese medicinal composition for treating rheumatism rheumatoid arthritis and osteosis - Google Patents

Chinese medicinal composition for treating rheumatism rheumatoid arthritis and osteosis Download PDF

Info

Publication number
CN100394925C
CN100394925C CNB031559255A CN03155925A CN100394925C CN 100394925 C CN100394925 C CN 100394925C CN B031559255 A CNB031559255 A CN B031559255A CN 03155925 A CN03155925 A CN 03155925A CN 100394925 C CN100394925 C CN 100394925C
Authority
CN
China
Prior art keywords
weight portion
rheumatoid arthritis
osteosis
weight
chinese medicine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB031559255A
Other languages
Chinese (zh)
Other versions
CN1589859A (en
Inventor
陈帮映
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CNB031559255A priority Critical patent/CN100394925C/en
Publication of CN1589859A publication Critical patent/CN1589859A/en
Application granted granted Critical
Publication of CN100394925C publication Critical patent/CN100394925C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention discloses a Chinese medicinal composition used for treating rheumatism, rheumatoid arthritis and osteosis, which is prepared from scorpion, centipede, earthworm, pangolin, eupolyphage sinensis, silky ant, long-noded pit viper and xylotrupes as raw medicinal materials. The present invention has significant effect on treating rheumatism, rheumatoid arthritis and osteosis.

Description

A kind of Chinese medicine composition for the treatment of rheumatism, rheumatoid arthritis and hyperosteogeny
Technical field
The present invention relates to a kind of pharmaceutical composition, particularly relate to a kind of Chinese medicine composition for the treatment of rheumatism, rheumatoid arthritis and hyperosteogeny
Background technology
Rheumatism is that a kind of common clinical, frequently-occurring disease, disease cycle are longer, and the clinical symptoms performance is various, the stubborn disease that the treatment phase is long.Hyperosteogeny is the aged a kind of performance of skeleton, also is one of common frequently-occurring disease of old people.Present domestic medical circle treatment hyperosteogeny main method has: traction, massage, surgical operation etc., and these Therapeutic Method cause very big misery to the patient, and the treatment condition has certain limitation, dangerous big, the course of treatment is long, and body is had damage, weak effect, more rate is low in treatment, easily recurrence.
Technology contents
The object of the present invention is to provide a kind of pharmaceutical composition that treatment rheumatism, rheumatoid arthritis, hyperosteogeny is had remarkable result.
The present invention is achieved through the following technical solutions:
Choose crude drug
Scorpio 10-50 weight portion Scolopendra 10-50 weight portion Pheretima 20-100 weight portion
Squama Manis 30-120 weight portion Eupolyphaga Seu Steleophaga 30-120 weight portion Formica fusca 50-150 weight portion
Agkistrodon 30-120 weight portion Catharsii molossi 20-100 weight portion
Optimum ratio of the present invention is:
Scorpio 30 weight portion Scolopendras 30 weight portion Pheretimas 50 weight portions
Squama Manis 60 weight portion Eupolyphaga Seu Steleophagas 60 weight portion Formica fuscas 100 weight portions
Agkistrodon 60 weight portion Catharsii molossis 50 weight portions
Press practice of pharmacy, compositions of the present invention can be added adjuvant and be prepared into the various clinical pharmaceutical dosage form, comprise any in tablet, capsule, granule, pill, suspensoid, drop pill, the oral liquid.
Described adjuvant is meant conventional excipient, as solvent, disintegrating agent, correctives, antiseptic, coloring agent, binding agent etc.
Following experimental example is used to further specify the present invention.
Clinical data:
This clinical verification was observed from year February in February, 2000 to 2003, and the utilization present composition is treated rheumatism, rheumatoid arthritis, hyperosteogeny patient's 650 examples, wherein male 390 examples, women 260 examples altogether.Instructions of taking every day 3 times, each 4, two weeks were a course of treatment.The present invention treats rheumatism, rheumatoid arthritis, hyperosteogeny effective percentage 90%, cure rate 81%.
Model case:
Case 1: Jiang XX woman went to a doctor on August 28th, 56 years old.Extremities joint swelling distortion 5 years, sharp ache, difficulty in walking, through the multi-treatment poor effect, health is become thin, and purplish tongue is dark, thready and hesitant pulse.Look into: erythrocyte sedimentation rate 70mm/h, anti-" 0 " positive.Diagnosis: rheumatoid arthritis.Treatment: control the numbness sheet through clothes Chen Shi wind dispelling of the present invention, every day 3 times, each 4, swelling pain alleviates after the week, and 9 months complete, follows up a case by regular visits to and do not have recurrence in 2 years.
Case 2: what XX man 53 years old, suffered from lumbar vertebra hyperosteogeny disease 7 years, waist sacrum and lumbar and back pain are acutely accompanied moving obstacle unbearably, weakness of the waist and knees, erythrocyte sedimentation rate 80mm/h, Chinese medical discrimination: caused by liver and kidney deficiency silt essential resistance of turbid.Treatment: obey Chen Shi wind dispelling of the present invention and control the numbness sheet, every day 3 times, each 4, pain is basic after 3 days alleviates, and heals entirely after half a year.
Following embodiment all can realize the effect of above-mentioned experimental example.
Embodiment 1
Scorpio 30g Scolopendra 30g Pheretima 50g Squama Manis 60g Eupolyphaga Seu Steleophaga 60g
Formica fusca 10g Agkistrodon 60g Catharsii molossi 50g.
Said medicine technology is routinely made tablet, and every contains crude drug 0.5g, every day 3 times, each 4.
Embodiment 2:
Scorpio 25g Scolopendra 25g Pheretima 55g Squama Manis 65g Eupolyphaga Seu Steleophaga 55g
Formica fusca 15g Agkistrodon 55g Catharsii molossi 55g.
Said medicine technology is routinely made tablet.

Claims (3)

1. Chinese medicine composition for the treatment of rheumatism, rheumatoid arthritis and hyperosteogeny is characterized in that said composition made by following crude drug:
Scorpio 10-50 weight portion Scolopendra 10-50 weight portion Pheretima 20-100 weight portion
Squama Manis 30-120 weight portion Eupolyphaga Seu Steleophaga 30-120 weight portion Formica fusca 50-150 weight portion
Agkistrodon 30-120 weight portion Catharsii molossi 20-100 weight portion.
2. Chinese medicine composition according to claim 1 is characterized in that said composition made by following crude drug:
Scorpio 30 weight portion Scolopendras 30 weight portion Pheretimas 50 weight portions
Squama Manis 60 weight portion Eupolyphaga Seu Steleophagas 60 weight portion Formica fuscas 100 weight portions
Agkistrodon 60 weight portion Catharsii molossis 50 weight portions.
3. Chinese medicine composition according to claim 1 and 2 is characterized in that said composition adds adjuvant and is prepared into any in tablet, capsule, granule, pill, suspensoid, drop pill or the oral liquid.
CNB031559255A 2003-08-27 2003-08-27 Chinese medicinal composition for treating rheumatism rheumatoid arthritis and osteosis Expired - Fee Related CN100394925C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB031559255A CN100394925C (en) 2003-08-27 2003-08-27 Chinese medicinal composition for treating rheumatism rheumatoid arthritis and osteosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB031559255A CN100394925C (en) 2003-08-27 2003-08-27 Chinese medicinal composition for treating rheumatism rheumatoid arthritis and osteosis

Publications (2)

Publication Number Publication Date
CN1589859A CN1589859A (en) 2005-03-09
CN100394925C true CN100394925C (en) 2008-06-18

Family

ID=34598245

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB031559255A Expired - Fee Related CN100394925C (en) 2003-08-27 2003-08-27 Chinese medicinal composition for treating rheumatism rheumatoid arthritis and osteosis

Country Status (1)

Country Link
CN (1) CN100394925C (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102836177B (en) * 2012-09-13 2014-10-01 杜晓光 Traditional Chinese medicine preparation for treating osteopathia
CN103585350A (en) * 2013-11-28 2014-02-19 刘相英 Traditional Chinese medicine for treating rheumatism
CN103655915A (en) * 2013-11-28 2014-03-26 刘相英 Capsule for treating rheumatoid bone diseases
CN105853518A (en) * 2016-05-24 2016-08-17 刘金海 Traditional Chinese medicine composition for treating rheumatoid diseases and preparation method thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1433787A (en) * 2002-01-19 2003-08-06 马献山 Oral taken and external use medicine for antirheumatism and stopping numbness pain

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1433787A (en) * 2002-01-19 2003-08-06 马献山 Oral taken and external use medicine for antirheumatism and stopping numbness pain

Also Published As

Publication number Publication date
CN1589859A (en) 2005-03-09

Similar Documents

Publication Publication Date Title
CN102836177B (en) Traditional Chinese medicine preparation for treating osteopathia
CN100506274C (en) Traditional Chinese medicine for treating cervical vertebra disease
CN100571770C (en) A kind of Chinese medicine cutaneous permeable agent
CN101926957A (en) Medicinal composition for treating arthralgia syndrome and preparation method thereof
CN101129640A (en) Medicine for reliving inflammation and pain
CN102178807A (en) Plaster for treating traumatic injury, pain in neck, waist and lower extremities, and rheumatoid arthritis
CN102078527A (en) Traditional Chinese medicine formula for treating urinary calculus
CN100394925C (en) Chinese medicinal composition for treating rheumatism rheumatoid arthritis and osteosis
CN103356848A (en) Traditional Chinese medicine and preparation method thereof as well as Chinese herba preparation and preparation method of plaster
CN1389255A (en) Composite Chinese medicine for treating rheumarthritis and rheumatoid arthritis
CN100409894C (en) Chinese proprietary medicine for treating cerebral thrombosis
CN103393897B (en) Externally used traditional Chinese medicine for treating hyperostosis and rheumatic ostealgia and preparation method thereof
CN103751218A (en) Traditional Chinese medicine composition for treating rheumatic and rheumatoid arthritis and osteoproliferation
CN105267321A (en) Medicine for treating gouty arthritis
CN102406870A (en) Medicament for treating rheumatic arthralgia
CN102430096B (en) Medicament for treating rheumatic or rheumatoid diseases
CN101647880A (en) Medicament for treating appendicitis and preparation method thereof
CN101985013A (en) Chinese herbal medicine for treating rheumatic arthritis
CN101804179B (en) Traditional Chinese medicine composition for treating hyperosteogeny of cervical vertebra and lumbar vertebra and preparation method thereof
CN101195002B (en) Chinese medicine emplastrum for releasing ache and health care
CN1899564B (en) External use medicine for treating hyperosteogeny and protrusion of intervertebral disc
CN101361934B (en) Traditional Chinese medicine preparation for treating arthritis and various osteonosus
CN103585294A (en) Plaster for treating osteoproliferation and preparation method of plaster
CN102614350A (en) Chinese medicine for treating cervical spondylosis
CN103893436B (en) A kind of externally applied drug for treating rheumatism

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20080618

Termination date: 20110827